Cargando…
Intranasal Salvinorin A Improves Long-term Neurological Function via Immunomodulation in a Mouse Ischemic Stroke Model
Salvinorin A (SA), a highly selective kappa opioid receptor agonist, has been shown to reduce brain infarct volume and improve neurological function after ischemic stroke. However, the underlying mechanisms have not been fully understood yet. Therefore, we explored whether SA provides neuroprotectiv...
Autores principales: | Misilimu, Dilidaer, Li, Wei, Chen, Di, Wei, Pengju, Huang, Yichen, Li, Sicheng, Grothusen, John, Gao, Yanqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726789/ https://www.ncbi.nlm.nih.gov/pubmed/34596819 http://dx.doi.org/10.1007/s11481-021-10025-4 |
Ejemplares similares
-
Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury
por: Wei, Pengju, et al.
Publicado: (2021) -
Interleukin 13 promotes long-term recovery after ischemic stroke by inhibiting the activation of STAT3
por: Chen, Di, et al.
Publicado: (2022) -
Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model
por: Chen, Chunhua, et al.
Publicado: (2014) -
Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
por: Cichon, Joseph, et al.
Publicado: (2022) -
The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis
por: Paton, Kelly F., et al.
Publicado: (2021)